Fairholme Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.59M Hold
231,000
– – 0.43% 8
2026
Q2
$5.56M Buy
+231,000
New +$6.04M 0.37% 8

Other funds holding PFE

Fairholme Capital Management's PFE Position: Q3 2026 in Review

Fairholme Capital Management held its Pfizer (PFE) position steady in Q3 2026 at 231,000 shares worth $6.59M. The position accounts for 0.43% of the portfolio, ranked #8.

Fairholme Capital Management first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Fairholme Capital Management held 231,000 shares of Pfizer worth $6.59M as of Q3 2026.
  • Fairholme Capital Management left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.43% of Fairholme Capital Management's portfolio in Q3 2026, its #8 holding.
  • Fairholme Capital Management first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Fairholme Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.